Europe Probiotic Infant and Child Formula Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, and Distribution Channel

The probiotic infant and child formula in Europe is expected to grow from US$ 826.43 million in 2022 to US$ 1,755.33 million by 2028. It is estimated to grow at a CAGR of 13.4% from 2022 to 2028.

Breastmilk is the ideal food for infants as it is safe, clean, and contains antibodies that help protect against many common childhood illnesses. Breastmilk provides the child with all the energy and nutrients that are required for the first few months after birth, and it continues to provide up to half or more of a child’s nutritional needs. According to various surveys and reports, breastfeeding is declining for various reasons, including women's participation in the labor force. For instance, according to the Office for National Statistics (ONS) of the UK, the employment statistics of mothers grew from 66.2% in 2000 to 75.1% in 2019. Thus, the increased participation of women in the labor force is reducing breastfeeding and is driving the demand for probiotic infant and child formulas. According to the CDC, 17% of babies are supplemented with formula during the first two days of life, and ~35% of babies older than 6 months are fed breastmilk and formula. Thus, the rise in the number of women participating in the labor force is driving the growth of the Europe probiotic infant and child formula market.

Market Overview

The Europe probiotic infant and child formula market is segmented into Germany, France, Italy, the UK, Russia, and the rest of Europe. The market growth is fuelled by a rising fertility rate. According to the European Commission, the total fertility rate in the European Union increased from 1.43 live births per woman in 2001 to 1.50 live births per woman in 2020. Additionally, infant formula and growing-up formula are majorly used by working mothers to provide healthy and nutritious food for their babies. A growing focus on infant care and nutrition, changing lifestyles, rising middle-class population, and increasing purchasing power and disposable income of people in economies (including the UK, Germany, and France) are expected to propel the probiotic infant and child formula market growth in Europe during the forecast period.

Europe Probiotic Infant and Child Formula Market Segmentation

The Europe probiotic infant and child formula is segmented into type, distribution channel, and country.

• Based on type, the market is segmented into infant formula (0-1 year) and growing-up formula (1-6 years). The growing-up formula (1-6 years) segment registered the larger market share in 2022.
• Based on distribution channel , the market is segmented into online and offline. The offline segment held the larger market share in 2022.
• Based on country, the market is segmented into Germany , France ,Italy , UK , Russia and Rest of Europe. Russia dominated the market share in 2022. Nestlé S.A. ; HiPP GmbH & Company Vertrieb KG ; Abbott Laboratories and Mead Johnson & Company, LLC are the leading companies operating in the probiotic infant and child formula in the region.